Xollent Biotech, Inc. — Form D
Xollent Biotech, Inc. of RALEIGH, NC, a company, filed a Form D exempt-offering notice with the SEC on 2018-05-17. The offering totals $1.0M, of which $50K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-05-17
- Form: D
- Accession: 0001740943-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $50K
- Remaining: $950K
- Investors: 1
- Date of first sale: 2018-05-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-312656
Issuer
- Name: Xollent Biotech, Inc.
- CIK: 0001740943
- Entity type: Corporation
- Jurisdiction: NORTH CAROLINA
- Incorporated: 2017
- Address: 621 HUTTON STREET, RALEIGH, NC, 27606
- Phone: 9195136157
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Ke Cheng | Director | RALEIGH, NC |
| Weili Zhou | Director | RALEIGH, NC |
| Ke Cheng | Executive Officer | RALEIGH, NC |
| Dongmei Zhu | Executive Officer | Raleigh, NC |
More